These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis. Sagaram M; Parthasarathy R; Condon SL; Closson CF; Kong M; Schwandt ML; Jophlin LL; Feng W; Barve AJ; Vatsalya V Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628661 [TBL] [Abstract][Full Text] [Related]
7. Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate. Singal AK; DiMartini A; Leggio L; Arab JP; Kuo YF; Shah VH Alcohol Alcohol; 2022 Sep; 57(5):576-580. PubMed ID: 35544033 [TBL] [Abstract][Full Text] [Related]
8. Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder. Vannier AGL; Shay JES; Fomin V; Patel SJ; Schaefer E; Goodman RP; Luther J JAMA Netw Open; 2022 May; 5(5):e2213014. PubMed ID: 35594048 [TBL] [Abstract][Full Text] [Related]
9. Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy. Tarli C; Mirijello A; Addolorato G Semin Liver Dis; 2022 May; 42(2):138-150. PubMed ID: 35292951 [TBL] [Abstract][Full Text] [Related]
10. Alcohol use disorder and the liver. Buchanan R; Sinclair JMA Addiction; 2021 May; 116(5):1270-1278. PubMed ID: 32710592 [TBL] [Abstract][Full Text] [Related]
11. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes. Shen NT; Londono C; Gold S; Wu A; Mages KC; Brown RSJ World J Gastroenterol; 2019 Apr; 25(13):1628-1639. PubMed ID: 30983822 [TBL] [Abstract][Full Text] [Related]
12. Serum IgA levels and IgA/IgG ratio in Alcoholic Liver Disease. BhatB NM J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443491 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease. Addolorato G; Ponziani FR; Dionisi T; Mosoni C; Vassallo GA; Sestito L; Petito V; Picca A; Marzetti E; Tarli C; Mirijello A; Zocco MA; Lopetuso LR; Antonelli M; Rando MM; Paroni Sterbini F; Posteraro B; Sanguinetti M; Gasbarrini A Liver Int; 2020 Apr; 40(4):878-888. PubMed ID: 31951082 [TBL] [Abstract][Full Text] [Related]
14. Salvianic acid A alleviates chronic alcoholic liver disease by inhibiting HMGB1 translocation via down-regulating BRD4. Lan Y; Yan R; Shan W; Chu J; Sun R; Wang R; Zhao Y; Wang Z; Zhang N; Yao J J Cell Mol Med; 2020 Aug; 24(15):8518-8531. PubMed ID: 32596881 [TBL] [Abstract][Full Text] [Related]
15. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Arab JP; Izzy M; Leggio L; Bataller R; Shah VH Nat Rev Gastroenterol Hepatol; 2022 Jan; 19(1):45-59. PubMed ID: 34725498 [TBL] [Abstract][Full Text] [Related]
16. Indications for and outcomes of liver transplantation in patients with alcohol-associated liver disease. Phillips PK; Caldis MW; Hristov AD; Lee AS; Lucey MR Minerva Gastroenterol Dietol; 2018 Jun; 64(2):126-137. PubMed ID: 29243894 [TBL] [Abstract][Full Text] [Related]
17. Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis. Winters AC; May FP; Wang Y; Shao P; Yang L; Patel AA Drug Alcohol Depend Rep; 2021 Dec; 1():100004. PubMed ID: 36843910 [No Abstract] [Full Text] [Related]
18. Substance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder. Vannier AGL; Fomin V; Chung RT; Patel SJ; Schaefer E; Goodman RP; Luther J Gastro Hep Adv; 2022; 1(3):403-408. PubMed ID: 35474707 [TBL] [Abstract][Full Text] [Related]
19. The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors. Anouti A; Mellinger JL Semin Liver Dis; 2023 Feb; 43(1):50-59. PubMed ID: 36529138 [TBL] [Abstract][Full Text] [Related]